Dynamic ensembles hold great promise in advancing RNA-targeted drug discovery. Here we subjected the transactivation response element (TAR) RNA from human immunodeficiency virus type-1 to experimental high-throughput screening against ~100,000 drug-like small molecules. Results were augmented with 170 known TAR-binding molecules and used to generate sublibraries optimized for evaluating enrichment when virtually screening a dynamic ensemble of TAR determined by combining NMR spectroscopy data and molecular dynamics simulations. Ensemble-based virtual screening scores molecules with an area under the receiver operator characteristic curve of ~0.85-0.94 and with ~40-75% of all hits falling within the top 2% of scored molecules. The enrichment decreased significantly for ensembles generated from the same molecular dynamics simulations without input NMR data and for other control ensembles. The results demonstrate that experimentally determined RNA ensembles can significantly enrich libraries with true hits and that the degree of enrichment is dependent on the accuracy of the ensemble.
T he discovery of regulatory noncoding RNAs (ncRNAs) has been accompanied by a growing interest in targeting RNA using small molecules for therapeutics development [1] [2] [3] [4] [5] . Small molecules enjoy favorable pharmacological properties and do not suffer from delivery limitations inherent to oligonucleotide-based therapeutics 5 . However, targeting RNA with small molecules comes with a unique set of challenges. Most ncRNAs are nonenzymatic, making it difficult to directly screen for inhibitors. Highthroughput screening (HTS) assays targeting RNA often yield hits with low specificity, unfavorable pharmacological properties, and/ or poor activity in cell-based assays. Additionally, libraries used in HTS are biased to compounds that bind the deep hydrophobic pockets of proteins, not the polar and solvent exposed pockets typical of RNA targets. Rational approaches to identify small molecules that bind specific RNA secondary structures have had some success 6 , but achieving the desired selectivity and efficacy is difficult, given the prevalence of similar secondary structural motifs across the transcriptome.
Structure-based approaches such as computational docking 7,8 potentially provide a powerful means to broadly prescreen compound libraries and generate sublibraries enriched with diverse compounds that selectively bind the unique pockets of ncRNAs. However, applying virtual screening (VS) to RNA drug targets is complicated by the high flexibility of RNA and its propensity to undergo large conformational changes upon small-molecule binding 9 . Several approaches have been developed to address protein flexibility, including 'soft docking' 10 , methods that vary side chain rotamers 11 , and induced-fit docking 12 . Unfortunately, none of these approaches can treat the large conformational changes accompanying RNA recognition while maintaining the high computational efficiency needed for VS applications. An alternative approach treats the receptor as an ensemble of many conformations each of which is subjected to VS [13] [14] [15] (reviewed in refs 7, 8 ). However, the force fields used in molecular dynamics (MD) simulations to generate ensembles of conformations remain underdeveloped and poorly tested for RNA 16, 17 . Because of this, and because of the much higher flexibility of RNA 16, 17 , there is a greater risk of including artifactual conformations in the ensemble that are rarely sampled in solution, leading to false positives in VS [18] [19] [20] . There is also a greater risk of not sampling conformers with favorable binding pockets because of RNA's more rugged energy landscape and high propensity for kinetic traps 21 , thus increasing the likelihood of false negatives.
Recent approaches that combine experimental data with computational methods are making it possible to determine ensembles of proteins and nucleic acids at atomic resolution [22] [23] [24] [25] [26] . Notably, ensembles of the apo-state determined using these hybrid approaches often include conformations similar to those observed for the biomolecule when bound to cognate partners [23] [24] [25] . Inspired by these discoveries, we 9 and others 27, 28 have carried out ensemble-based VS (EBVS) using experimentally informed ensembles. The utility of this approach in targeting RNA was demonstrated in a prospective study 9 using an ensemble of the transactivation response element (TAR) RNA from human immunodeficiency virus type-1 (HIV-1; Fig. 1a ). The ensemble was determined using two sets of NMR residual dipolar coupling (RDC) data 29, 30 to guide selection of conformations from a pool generated using MD simulations 23 . RDCs depend on the orientation of bond vectors in a biomolecule relative to a molecule-fixed alignment frame and are sensitive to internal motions spanning a broad range of timescales (picosecond to millisecond) 29, 30 . The 57 top-scoring small molecules out of a screen of 51,000 compounds included six molecules that bind TAR in vitro. These include the first example of a small molecule that binds an RNA apical loop and an aminoglycoside that binds TAR with high selectivity, inhibiting HIV replication (50% inhibition concentration (IC 50 ) ∼ 20 μ M) in an indicator cell line 9 .
A critical evaluation of VS requires retrospective studies that test the ability of docking to discriminate between known hits and nonhits 31 . Such studies are routine in protein applications but have been scarce for RNA. Thus far, to our knowledge, no study has evaluated the utility of experimentally informed RNA ensembles in enriching
High-performance virtual screening by targeting a high-resolution RNA dynamic ensemble
The 267 confirmed hits were tested in dose-response assays yielding 17 hits with competitive doses to displace 50% of Tat peptide (CD 50 ) values < 100 μ M. These compounds were repurchased and retested for TAR binding using the displacement assay and NMR chemical shift mapping experiments. This yielded six confirmed hits ( Table 1 and Supplementary Fig. 1 ) and identified three false positives (see Methods and Supplementary Fig. 2 ). To limit false negatives, we retested 56 nonhits with chemical similarity to the hits using dose-response assays and NMR experiments. This resulted in the identification of one additional hit (Table 1 and Supplementary Fig. 1 ) and confirmation of many nonhits with high chemical similarity to our hits (examples in Supplementary  Fig. 3 ). The fact that small structural changes can ablate binding is consistent with the hit molecules making specific interactions with TAR.
To test for false negatives, we retested ten nonhits that scored in the top 5% of EBVS using NMR. Four molecules were identified that bind TAR, including an aminoglycoside that was missed in HTS due to insolubility in DMSO, a weak binder that did not satisfy our hit criteria, and two compounds whose binding affinities could not be verified due to fluorescence interference effects (see Methods and Supplementary Fig. 4 ). These compounds were removed from the VS libraries to avoid biasing results. These results highlight potential weaknesses in experimental HTS and provide a blind test for EBVS to identify TAR binders. Overall, HTS yielded seven hits, which represent two novel classes of RNA-binding small molecules ( Table 1) . Five of the hit molecules share an anthraquinone scaffold, while the other two have naphthyl and quinazoline cores. The anthraquinone molecules show selectivity relative to transfer RNA (tRNA; Table 1 ) and were inactive in a microRNA screen (A.L. Garner, University of Michigan; personal communication). Of particular relevance to this study, the HTS yielded 103,349 experimentally verified nonhits that can be used as decoys to test the performance of EBVS.
Building small-molecule libraries for EBVS evaluation. The HTS library was augmented with 170 diverse small molecules reported in the literature to bind TAR with dissociation or inhibition constants that satisfy our hit criteria (see Supplementary Note 1 and Supplementary Table 1 ). The hits include derivatives of beta-carboline, quinolone, diphenylfuran, nucleosides, aminoglycosides, and many others, as well as 36 molecules with demonstrated activity in cell (or cell-extract) based assays. To avoid bias and maximize chemical diversity, the 177 hits were clustered based on Bemis-Murcko atomic frameworks, and the compound with highest affinity selected as a representative of each scaffold. This resulted in the 'Full' library consisting of 78 hits (19 with cell-based activity) and 103,349 nonhits.
The chemical properties of hits and nonhits in the Full library are markedly different ( Fig. 1c ). On average, the hits, which include several aminoglycosides, have larger molecular weights, larger charges, higher numbers of rotatable bonds, more hydrogen bond donors and acceptors, and lower log(P) values. Similar differences between RNA binders and compound libraries used in HTS have been noted previously 35 . Such differences can lead to artificial enrichment in VS by biasing docking scores for hits versus nonhits based solely on differences in one-dimensional (1D) chemical properties and not three-dimensional (3D) structure complimentarity 31, 36 . We therefore generated two additional property-matched libraries that provide a more stringent test for docking-based enrichment (see Supplementary Note 1). A 'Filtered' library, containing 26 hits (8 with cell-based activity) and 102,307 nonhits, was generated by omitting small molecules with outlier chemical properties ( Fig. 1c and Supplementary Fig. 5 ). An 'Optimized' library, containing 14 hits (5 with cell-based activity) and 637 nonhits, was generated following the general protocol for decoy generation used in the DUD-E 31 for protein applications, in which a set number of property-matched and topologically distinct nonhits are selected for each hit ( Fig. 1c and Supplementary Figs. 5 and 6a,b). Together, the three small-molecule libraries provide the means to robustly evaluate the performance of VS against TAR RNA. Ensemble based virtual screening. EBVS was carried out against a recently reported RDC-informed dynamic ensemble (E 0,4rdc ) of HIV-1 TAR RNA ( Fig. 2a ) 24 . The ensemble contains 20 unique and equally populated (5% each) conformations 24 . Compared to the previous TAR ensemble used in VS 9, 23 (see E 1,2rdc below), this ensemble was determined using four rather than two sets of RDCs 17 and a longer MD simulation (8.2 μ s versus 80 ns) to generate the starting pool of TAR conformations 24 . The TAR ensemble displays a high degree of flexibility; the pairwise r.m.s. deviation (RMSD) between any two conformations is > 1.9 Å and on average 5.9 Å. This substantially exceeds the flexibility of most protein targets, presenting a considerable challenge to docking based approaches. Each small molecule was docked against every TAR conformer using internal coordinate mechanics 37 . Each small molecule was assigned a docking score corresponding to the best score across the 20 conformers, a Boltzmann-weighted average score, or an arithmetic average score (see Methods). The global enrichment of true binders was assessed based on the area under the curve (AUC) of a receiver operator characteristic (ROC) curve, with AUC = 1.0 representing perfect enrichment and AUC = 0.5 representing random selection of hits and nonhits. For the Full library, optimal enrichment was obtained using the Boltzmann average or best score, whereas the arithmetic average yielded slightly better enrichment for the Filtered and Optimized libraries ( Supplementary Fig. 6c ). The Full library had larger variation in enrichment across scoring approaches because it contains molecules with highly varied docking scores across conformers. In what follows, we use the Boltzmann average score for the Full library and arithmetic average score for both Filtered and Optimized libraries. Results for all scoring approaches and for including all hits without clustering are presented in Fig. 2b and Supplementary Fig. 6c .
EBVS globally enriched the Full library with ROC AUC = 0.88, and 42% of hits were identified after screening only 2% of nonhits (ROC 2% = 42%; Fig. 2b ). This corresponds to a hit rate of 1.6% as compared to 0.075% when screening the entire library, and an enrichment factor (EF 2% ) of 21. Similar levels of enrichment were obtained for the Filtered (ROC AUC = 0.85 and ROC 2% = 50%) and Optimized (ROC AUC = 0.90 and ROC 2% = 57%) libraries ( Fig. 2b) . EBVS significantly enriched hits with cell-based activity with ROC AUC = 0.91-0.94 and ROC 2% = 40-75% ( Fig. 2b ). This performance is comparable to best-case results when docking to known bound structures of proteins [38] [39] [40] .
The enrichment was lower for individual TAR conformers derived from the ensemble and decreased further for single conformers randomly selected from the MD pool ( Fig. 2c and Supplementary  Fig. 7a ). Docking against the lowest energy NOE-based structure of free TAR (PDB 1ANR) 41 generally performed better than other single conformers, but consistently worse than EBVS ( Fig. 2c and Supplementary Fig. 7a ). Enrichment was also lower for an NMR structure of tRNA (PDB 1EHZ) 42 compared to the TAR ensemble ( Fig. 2c and Supplementary Fig. 7a ). The TAR binders, including those with cell activity, had higher scores on average for docking against tRNA compared to TAR, suggesting that VS would have identified these as selective TAR binders (Supplementary Table 2 ). The similar levels of enrichment observed across the three libraries when VS the ensemble, single conformers, or tRNA argues against significant artificial enrichment in the Full library.
Enrichment depends on ensemble size. On average, enrichment decreased when using smaller subensembles derived from the full N = 20 ensemble, reaching a minimum at N = 1 ( Fig. 3a and Supplementary Fig. 7b ). This is despite the fact that increasing the ensemble size increases the risk of including artifactual conformations that can lead to false positives [18] [19] [20] . The N = 20 TAR ensemble represents the smallest ensemble that satisfied the RDC data, with smaller ensembles failing to reproduce the RDCs to within experimental uncertainty 24 . Accordingly, the subensembles had dimin- ishing accuracy, as measured based on their agreement with the four RDC datasets (RDC RMSD; Fig. 3b ). Consequently, enrichment decreased, on average, with increasing RDC RMSD ( Fig. 3c ). Similar trends were observed for all libraries and for other ensembles (see below and Supplementary Fig. 7c,d) . These results show that all 20 conformations contributed to the high enrichment observed for TAR and suggest a correlation between enrichment and ensemble accuracy. Although all conformations contributed to enrichment, some conformers were predicted to be more or less preferentially bound across the Full library ( Supplementary Fig. 8a ), and the preferences were different for hit molecules relative to the Full library ( Supplementary Fig. 8b ). Notably, conformer 5, which most resembles a known ligand-bound TAR conformation, yielded the lowest docking score for many molecules across the Full library but was favored by a smaller percentage of hit molecules, suggesting a favorable but nonselective binding pocket ( Supplementary Fig. 8b ). Conformers 8, 10, and 17, which also most resemble known ligandbound TAR conformations, yielded the best docking scores for more hits than nonhits, although conformer 17 was also often selected by false-positive hits (top 2% scored nonhits; Supplementary Fig. 8b ).
Hyperenriching subensembles, which exhibit higher enrichment than the N = 20 parent ensemble, tended to be enriched in conformers that scored highly for hits compared to the Full library, such as conformer 2 ( Supplementary Fig. 8c ). On the other hand, conformers such as conformers 5 and 15 that were not favored by hit molecules relative to the library were found in fewer hyperenriching ensembles. Despite small variations, most conformers were not significantly under-represented (< 20%) or over-represented (> 80%) in hyperenriching ensembles, supporting that all conformers contributed to enrichment. Taken together, these results highlight how a given conformer can contribute positively to enrichment when placed within an appropriate subensemble, even though it may have poor enrichment when considered in isolation or in a different ensemble context. Enrichment depends on ensemble accuracy. We carried out EBVS on six additional N = 20 TAR ensembles with varying degrees of accuracy, as assessed by RDC RMSD (Fig. 3d ). E 0,4rdc , determined using four sets of RDCs and an MD generated pool (MD0), predicted the four RDC datasets with an optimal RMSD = 4.0 Hz. 41 . Note that the high RDC RMSD observed for E NOE is not surprising considering that NOE-derived distance restraints are orthogonal to RDC-derived orientational restraints and that the bundle of structures is not a statistical ensemble but rather a collection of single structures that satisfy the experimental constraints.
As shown in Fig. 3e , Supplementary Fig. 9a , and Table 2 , E 0,4rdc , which best satisfies the RDCs, robustly yielded the highest enrichment across the three libraries, whereas E 0,anti , which least satisfies the RDCs, generally yielded the lowest enrichment. The enrichments observed for the remaining ensembles fell between these extremes, and were generally better for the two experimentally informed ensembles (E 1,2rdc and E NOE ). The three purely computational ensembles (E 0,ran , E 0,clus , and E 1,ran ) showed substantial variations in enrichment, highlighting the risks of generating ensembles without experimental input. E 0,ran and E 0,clus had very similar RDC RMSDs but E 0,clus consistently yielded higher enrichment, showing that RDC RMSD was not the only predictor of enrichment. This is not surprising, considering that RDCs are insensitive to translational aspects of RNA structure that are likely important for predicting binding and considering that multiple degenerate ensembles can satisfy a given set of RDCs 43 . Differences in docking scores and binding pockets help explain the different enrichment levels observed across different ensembles ( Fig. 3f and Supplementary Fig. 9b) . The difference in scores between hits and nonhits was greater for E 0,4rdc relative to other ensembles. The average scores of hits for E 0,4rdc were lower than most other ensembles, consistent with formation of optimal pockets. E 1,2rdc and E 1,ran had comparatively lower average scores for nonhits, increasing the likelihood of false positives. Conformers in these ensembles tended to have larger binding pockets relative to other ensembles ( Supplementary  Fig. 9c ). The average scores for E 0,ran and E 0,anti were significantly elevated for both hits and nonhits, and correspondingly, they had smaller binding pockets on average ( Fig. 3f and Supplementary Fig.  9b ,c). All other ensembles had similar binding pocket sizes and accessibility, indicating that enrichment was not determined only by these gross binding pocket features ( Supplementary Fig. 9c ).
Enrichment correlates to overlap with ligand-bound conformations. We examined how well the different ensembles encompassed six previously determined NMR structures of ligand-bound TAR (acetylpromazine (1LVJ) 44 , rbt550 (1UTS) 45 , rbt203 (1UUD) 46 , rbt205 (1UUI) 46 , neomycin B (1QD3) 47 , and arginine (1ARJ) 48 ). First, we focused on the relative orientation of TAR helices, which is an important determinant of RNA binding pockets 49 and the least well modeled aspect of TAR in MD simulations 16 . The average interhelical orientation has also been independently validated for three ligand-bound TAR conformations based on order tensor analysis of RDCs for arginine 50 , acetylpromazine 51 , and neomycin B 51 . However, these RDC studies also highlighted uncertainty in the NOE-based structures, due to deviations in the local geometry and/or unaccounted flexibility (Supplementary Note 2 and Supplementary Fig. 10a ). Table 3 ). Data shown for molecules with number of rotatable bonds N flex < 11 (solid line) and N flex > 11 (dashed line). The RMSD values correspond to the best scoring pose over n = 20 independent docking runs. b, Benchmark RMSDs when redocking ligands to their X-ray (123 structures) or NMR (26 structures) RNA structure and for molecules with N flex < 11 (17 NMR structures and 90 X-ray structures) and N flex > 11 (9 NMR structures and 33 X-ray structures). Also shown are the RMSDs over n = 20 independent docking runs for each ligand-bound TAR NMR structure after redocking to the NMR structure (yellow) or when carrying out EBVS against E 0,4rdc (blue) and E 0,ran (red). Center line, median; center square, mean; box limits, 25th and 75th percentiles; whiskers, 5th and 95th percentiles; points, outliers. c, Lowest RMSD bound poses over n = 20 independent docking runs based on redocking the NMR structure (yellow) or when carrying out EBVS against E 0,4rdc (blue) or E 0,ran (red). All poses are superimposed onto the NMR structure (black) using the binding pocket and ligand.
Overall, ensembles that best overlapped with the ligand-bound conformations showed the best EBVS enrichment (Fig. 4a ). As noted previously 24 , E 0,4rdc encompassed the six ligand-bound TAR interhelical conformations despite a very broad MD0 pool. In contrast, E 0,anti , which showed the weakest enrichment, showed the poorest overlap with the ligand-bound conformations. Notably, E 0,clus , which showed better enrichment than either E 0,anti or E 0,ran , showed the most substantial overlap among the three computational ensembles. The MD1 pool had a different spread of interhelical angles than MD0 that did not overlap as well with the ligand-bound conformations. The ensembles derived from MD1 (E 1,2rdc , E 1,ran , and E NOE ) all showed intermediate overlap with the ligand-bound conformations.
Excluding neomycin B, the average interhelical conformations predicted by EBVS against E 0,4rdc were within the margin of error of the NMR structures for four of five molecules, and all five bend angles were within the margin of error (Fig. 4b) . In contrast, only two structures were within the margin of error for EBVS against E 0,ran ( Supplementary Fig. 10b ). In the case of neomycin B, docking prefers a conformer that differs considerably from the NMR structure. Here the larger size of neomycin B likely contributed to greater uncertainty in the docking predictions, as is observed in benchmark studies ( Fig. 5 and ref. 52 ).
Comparison of ligand-bound poses revealed that, with the exception of neomycin B, EBVS correctly placed the ligands within or near the RNA binding pocket defined by the NOE-based NMR structure. A more quantitative comparison is complicated by many factors, including the fact that EBVS predicts an ensemble of bound conformations rather than a single structure, by differences in NMR and EBVS-predicted RNA structures that complicate alignment, and by evidence for uncertainty in local aspects of the NOE-based NMR structure 50 that may arise from the dynamic nature of these complexes (Supplementary Note 2 and Supplementary Fig. 10a ). Notwithstanding the above complications, we compared the EBVSpredicted ligand poses with the NMR structures.
We first carried out benchmark studies by redocking known RNA ligand-bound structures ( Supplementary Table 3 ) and computing the ligand RMSD between the redocked pose and original NMR structure. For X-ray structures of RNA bound to ligands with less than 11 rotatable bonds (N flex < 11), we obtained a success rate of 72% for an RMSD cutoff of 2.5 Å (Fig. 5a ). However, the success rate dropped significantly for NMR structures or molecules with N flex > 11 (Fig. 5a ). These results highlight the fact that our docking protocol is able to recapitulate bound poses when the structure is well-defined and the molecule is not highly flexible.
To compare EBVS-predicted ligand poses to the NMR structures, we computed the ligand RMSD after superimposing structures using both the RNA binding pocket and ligand (see Methods). On average, EBVS predicted the ligand-bound poses (RMSD = 8.3 ± 3.5 Å (acetylpromazine), 7.0 ± 2.0 Å (arginine), 9.2 ± 1.8 Å (rbt205), 10.3 ± 3.4 Å (rbt550), 10.1 ± 3.3 Å (rbt203), and 17.1 ± 4.5 Å (neomycin B)) with an accuracy that was comparable to, albeit consistently slightly poorer than, those obtained when redocking the ligands against their NMR structure (RMSD = 4.9 ± 0.6 Å (acetylpromazine), 6.8 ± 0.9 Å (arginine), 7.1 ± 1.3 Å (rbt205), 8.9 ± 0.9 Å (rbt550), 8.0 ± 2.2 Å (rbt203), and 12.0 ± 1.8 Å (neomycin B); Fig. 5b ). These RMSDs were on the high end for redocking NMR structures (Fig. 5b ). This could be because the apo-ensemble did not perfectly reproduce the ligand-bound TAR conformations and/or because of uncertainty in the NOE-based NMR structures due to lack of RDC restraints and/ or unaccounted flexibility. When only considering the lowest RMSD pose over 20 docking runs, EBVS E 1,4rdc agreed better with the NMR structure than redocking the NMR structure itself for three of the six ligands, and EBVS against E 0,ran yielded the poorest agreement for all ligands except neomycin B (Fig. 5c ). In light of our benchmark study, the poor pose prediction of neomycin B may be attributed in part to its large number of rotatable bonds.
Discussion
Advances in hybrid experimental-computational methods are enabling the determination of dynamic ensembles with ever increasing accuracy. One of the emerging themes from studies thus far is that bound conformations of biomolecules are often significantly populated in the apo-state ensemble. Even though ensemblebased docking is becoming a popular method for treating flexibility during VS 7, 8, [13] [14] [15] , only three studies have subjected experimentally informed ensembles to VS 9, 27, 28 . Rather, static structures or purely computational ensembles are typically subjected to VS. Here we present the first perspective study evaluating the enrichment performance of VS experimentally informed ensembles and comparing it to that of computational ensembles.
While an ensemble of structures can often be identified that outperforms single X-ray or NMR structures in retrospective enrichment studies 53, 54 , identifying the successful ensemble in advance of VS can prove difficult 19, 55 . This is a considerable problem for RNA, given that a handful of conformers have to be selected from thousands of conformations as representatives of a broad conformational landscape. Our results emphasize the potential importance of conformational penalties 27 when developing and testing scoring functions against highly flexible RNA targets 9, 56 . In the case of TAR, the performance varies significantly when drawing N = 20 ensembles from the same MD pool without guidance from experimental data ( Fig. 3 and Table 2 ). Data from NMR, X-ray, or other methods can guard against artifactual conformations and guide identification of the most populated conformations, which carry the least conformational penalties for ligand binding [22] [23] [24] [25] [26] 57 . Experimentally informed conformer populations can also be directly translated into scoring penalties during EBVS 27 . Additionally, experimental data can define an optimally small ensemble for VS applications, whereas there is no general recipe for selecting ensemble size without experimental input 53, 55 . In the case of RDCs, it has been shown that the minimum sized ensembles that satisfy the data represent a data-driven clustering of the real ensemble 43 . Here the ensemble size is naturally tuned to the level of dynamics with greater flexibility calling for larger ensembles to satisfy the RDCs 43 .
Our study also highlights future challenges and opportunities in RNA VS applications. First, while our results indicate that EBVS significantly enriches compounds with activity in cell-based (or cellextract based) assays, there is a need to more directly assess the RNA binding selectivity of hits and to assess the ability of EBVS to enrich for selective RNA binders. Second, rigorous evaluation of pose predictions from EBVS against flexible ncRNA targets will require more high-resolution structures of RNA-small-molecule complexes by X-ray or NMR, so long as RDCs and other experimental restraints are used to improve the accuracy of NMR structures. Finally, there is room to further refine ensemble determination approaches by including low-populated conformational states that may have optimal binding pockets. For example, as noted previously 23, 24 , the experimentally informed TAR ensemble does not contain conformers with the U23-A27-U38 base triple, which forms on Arg recognition 50, 58 . The integration of conformational penalties from experimentally informed ensembles may help identify pitfalls in docking scoring functions that are currently obscured by treatment of RNA receptors as static structures. Notwithstanding the above future challenges, our results indicate that EBVS can immediately be applied to significantly enrich compound libraries with RNA binders.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0062-4.
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Methods HTS library composition. The small-molecule library used in experimental HTS consisted of 103,498 drug-like small molecules available at the Center for Chemical Genomics (CCG), University of Michigan, Ann Arbor. Of these, 100,000 molecules were synthetic organic molecules with drug-like properties (ChemDiv). The other 3,498 compounds consisted of 2,000 bioactive molecules (MicroSource Discovery Systems Inc.), 446 molecules (National Institute of Health clinical collection), and 1,052 molecules that the CCG had previously found to be active against other targets. The library was stored as 2-to 5-mM stock solutions in DMSO for ~3 years for initial screens. Repurchased molecules were stored as 3-to 20-mM stock solutions in DMSO for ~1 year, except for CCG-39701, which was stored as a powder and dissolved in water before use.
Preparation of HIV-1 TAR RNA and Tat peptide.
HIV-1 TAR for NMR and binding assays was prepared by in vitro transcription using a DNA template containing the T7 promoter (Integrated DNA Technologies). The DNA template was annealed at 50 μ M DNA in 3 mM MgCl 2 by heating to 95 °C for 5 min and cooling on ice for 30 min. The transcription reaction was carried out at 37 °C for 12 h with T7 RNA polymerase (New England BioLabs) in the presence of 13 C/ 15 N labeled or unlabeled nucleotide triphosphates (Cambridge Isotope Laboratories, Inc.). RNA was purified using 20% (w/v) denaturing PAGE with 8 M urea and 1X TBE. Purified RNA was extracted from the gel by electroelution in 1X TAE buffer and purified by ethanol precipitation. Purified RNA was dissolved in water to 50 μ M RNA, heated to 95 °C for 5 min and cooled on ice for 1 h to anneal. For NMR experiments, 13 C/ 15 N labeled RNA was exchanged into NMR buffer (15 mM NaH 2 PO 4 /Na 2 HPO 4 , 25 mM NaCl, 0.1 mM EDTA, 10% (v/v) D2O at pH 6.4). For in vitro assays, unlabeled RNA was diluted to 150 nM in Tris-HCl assay buffer (50 mM Tris-HCl, 50 mM KCl, 0.01% (v/v) Triton X-100 at pH 7.4).
The Tat peptide used in HTS, (5-FAM)-AAARKKRRQRRRAAA-Lys(TAMRA), was purchased (LifeTein) with purity > 95% as assessed by electrospray ionization mass spectrometry. The peptide was stored at − 20 °C as a 100-μ M stock solution in Tris-HCl assay buffer and diluted to 60 nM with assay buffer for use in HTS.
High-throughput screening. Assay. HTS used a previously described TAR-Tat displacement assay 60 . The Tat peptide is highly flexible when free in solution and becomes structured upon binding to TAR [61] [62] [63] . When the Tat peptide is flexible, its two terminal fluorophores, fluorescein and TAMRA, interact, and their fluorescence is quenched. Alternatively, in its extended form, bound to TAR, the fluorophores are held at a distance, allowing fluorescence resonance energy transfer (FRET) from fluorescein to TAMRA. Thus, as inhibitor displaces Tat, there is a decrease in fluorescence signal (excitation: 485 nm, emission: 590 nm). For these assays, we used 50 nM TAR and 20 nM Tat because this ratio gave the maximal fluorescence signal. In the literature, this assay commonly uses a 1:1 ratio of TAR to Tat, so the excess TAR in our assay resulted in higher CD 50 values and a relatively more stringent test of binding. Using neomycin B as a control, we found that the CD 50 obtained using our assay (CD 50 = 0.96 ± 0.42 μ M) was slightly higher than the same assay with a 1:1 ratio of TAR to Tat (CD 50 = 0.32 ± 0.10 μ M).
The library was tested in a primary screen using a single-point measurement (n = 1) and 260-fold excess molecule (50 nM TAR, 20 nM Tat, and 13 μ M molecule) followed by a confirmation screen of triplicate measurements (n = 3) for the 2,812 molecules that showed activity, defined as a change in fluorescence signal 3 s.d. above the negative control (Tat alone). Molecules were pin-tooled (200 nL) into opaque 384-well microplates by a Biomek FX 384-well nanoliter HDR (Beckman) and Mosquito X1 (TTP Labtech). TAR and Tat were dispensed with a Multidrop reagent dispenser (Thermo Scientific). Assay mixtures were incubated at room temperature (~25 °C) for 10-15 min before fluorescence measurements using a Pherastar plate reader (BMG Labtech). Each plate during HTS contained 16 wells of TAR and Tat without molecule (negative control) and 16 wells of Tat only (positive control). The Z-factor 64 was calculated for each microplate; the average Z-factor throughout the screening campaign was 0.71.
Dose response assays.
A total of 267 molecules with reproducible activity were tested in a dose-response assay, and those with CD 50 < 100 μ M were considered hits. Dose-response assays were performed such that the final assay concentrations were 50 nM TAR, 20 nM Tat, and 1-1,000 μ M molecule in assay buffer. Assays were performed in parallel with and without 100-fold excess bulk yeast tRNA to test specificity and in the absence of RNA (Tat only) to measure background signal. There were 137 molecules that caused fluorescence intensity change with Tat alone, suggesting they bound Tat; these were removed from further analysis. Assays were performed in opaque 384-well microplates and read with a Clariostar plate reader (BMG Labtech). Fluorescence signal was normalized to the highest intensity after subtracting background signal. Dose-response curves were fit to equation (1) with OriginPro (OrginLab) using the instrumental weighting method. Equation (2) was used to obtain CD 50 values,
where A 1 and A 2 are the lowest and highest signals, respectively; p is the hill slope; and logx0 is the logarithm to base 10 of the concentration at half response. All variables were allowed to float during the fit. Assays were measured in triplicate and the mean and s.d. is reported.
Validation of hits. The 17 small-molecule hits from the dose response assays were repurchased and retested for activity, in addition to 56 molecules with chemical similarity to these hits, defined as having > 80% similarity based on sphere exclusion clustering performed with the JKlustor package (ChemAxon). Next, 32 molecules, including all 17 hits and 15 chemically similar molecules with possible activity in the assay, were tested for TAR binding by NMR chemical shift titrations employing [ 13 C-1 H] SOFAST-HMQC NMR experiments 65 performed at 298 K on 600-MHz and 800-MHz Agilent spectrometers equipped with triple-resonance HCN cryogenic probes. 13 C/ 15 N-labeled TAR was exchanged into the NMR buffer. Concentrated stocks of molecule in DMSO were added to TAR such that no more than 10% (v/v) DMSO was added to the buffer. Free-TAR controls had equivalent volumes of DMSO to compensate for minor changes that may be induced by DMSO. Spectra were processed using nmrPipe 66 and SPARKY 67 .
Nine molecules were inactive in both the displacement assay and NMR when retested with fresh molecule, suggesting that the original activity was due to contamination or degradation. One of the 56 molecules with chemical similarity to the hits, CCG-133994, was active in both the displacement assay and NMR, despite not being identified as a hit in the primary screen. Three molecules had activity in the assay, but did not bind based on NMR chemical shift titrations. Inspection of the Tat-only controls for these molecules suggested that they likely bind Tat rather than TAR in the displacement assay ( Supplementary Fig. 2 ). These should have been identified earlier in the workflow, but the fluorescence change in the presence of Tat may not have been large enough. Overall, seven molecules were confirmed to bind TAR RNA based on their activity in the TAR-Tat displacement assay and on their ability to induce chemical shift perturbations in the TAR NMR spectra ( Table 1 and Supplementary Fig. 1 ).
Hit molecules. The anthraquinone hits and chemically similar molecules exhibited a color change from orange to blue when diluted from 100% DMSO to an aqueous solution, likely due to DMSO reacting with the anthraquinone to form DMSOanthraquinone, as described previously 68 . All experiments were performed with the derivatives in the blue state. The addition of the small-molecule hits to TAR resulted in large chemical shift perturbations or line broadening in 2D NMR spectra for several residues throughout TAR ( Supplementary Fig. 1b ). As expected, hits with similar chemical structures induced similar chemical shift perturbations, indicating that they interacted with TAR via similar binding modes ( Supplementary Fig. 1b ). There were, however, two noteworthy exceptions. One of the five anthraquinone molecules, CCG-133905, induced substantially more broadening consistent with tighter binding and/or partial aggregation ( Supplementary Fig. 1 ). CCG-133994, which contains an ester and an amine, induced chemical shift perturbations that were distinct from the other anthraquinone molecules, suggesting a distinct binding mode for this molecule ( Supplementary Fig. 1 ). Furthermore, NMR revealed that CCG-133994 was in slow exchange, which is in agreement with it being the tightest binder in the TAR-Tat displacement assays.
Identification of false negatives. To investigate possible false negatives in the HTS, we selected ten molecules in the top 5% of docking scores and tested them for TAR binding using NMR. Four of the ten molecules did in fact bind TAR under NMR conditions ( Supplementary Fig. 4 ). Closer analysis revealed that different factors led to the exclusion of these small molecules from HTS during the primary screen. One aminoglycoside molecule, CCG-39701, was insoluble in DMSO but was active in the assay when dissolved in water ( Supplementary Fig. 4 ). CCG-174885 does not displace the Tat-peptide strongly enough to be a hit in our assay, but NMR clearly showed that it did bind TAR. The other two molecules, CCG-208298 and CCG-100975, had fluorescence interferences at high concentration, preventing determination of an accurate CD 50 ( Supplementary Fig. 4 ). To avoid biasing results, these molecules were not included in EBVS. Although these results demonstrate sources of uncertainty in our HTS results, our database is still based on more experimental data than the current standard of docking decoys, and our Optimized library should limit the number of false negatives by removing molecules topologically similar to hit molecules (see below). These results also provide a blind test of EBVS since we were able to identify TAR binders.
Virtual screening. VS was performed using the docking program Internal Coordinate Mechanics (ICM, Molsoft) 37 . The protocol allowed full ligand flexibility and rigid receptors. Docking was set up as described previously 19 . Briefly, each of the 20 conformers of the TAR dynamic ensemble 34 was uploaded to ICM in PDB format and converted to ICM objects using the default options (waters deleted and hydrogens optimized). Binding pockets were identified with the ICM PocketFinder Module using a tolerance value of 4.6. The volume and buriedness of the binding pocket were given by ICM. Receptor maps were generated to include all atoms within 5 Å of the predicted binding pockets, with atom occupancy weighted. Docking was run with a thoroughness value of 1, flexible ring sampling level 2, and covalent geometry relaxed. Protonation states of the small molecules were assigned in ICM at pH 7 with the exception of neomycin B, which was manually assigned a charge of + 5 based on previous reports 69 . The Full library was docked to each ensemble a single time for the enrichment studies. Docking against the parent E 0,4rdc ensemble was replicated and shown to give similar scores/enrichment (ROC AUC/ROC 2% = 0.88/42%, 0.81/35%, 0.87/50% for Full, Filtered, and Optimized libraries, respectively).
Ensemble-based docking scores. The docking scores provided by ICM represent predicted binding energies in kcal/mol. For each molecule, a composite score across all conformers was assigned as the arithmetic average, the top score, or the Boltzmann-weighted average. To calculate the Boltzmann-weighted average, the fractional population of all 20 TAR conformers was calculated using the Boltzmann distribution (equation (3)). The population of each conformer was multiplied by its docking score, and these values were summed over all conformers to calculate the population-weighted score of each molecule (equation (4)).
Where p i is the population of conformer i, ε i is the docking score of conformer i, R is the gas constant (1.987 × 10 −3 kcal K −1 mol −1 ), T is temperature (298 K), and M is the number of conformers in the ensemble.
Receiver operator characteristic curves. An in-house Python script was used to generate the ROC plots using equations (5) and (6) where n is the number of true negatives (TN), true positives (TP), false negatives (FN), or false positives (FP) at every possible score threshold.
Generating TAR ensembles. The RDC-derived TAR ensembles (E 0,4rdc and E 1,2rdc ) were determined as reported previously 23, 24 . Note that no RDCs were measured in the TAR apical loop and that this structure is not directly informed by experimental data. The NOE-based NMR ensemble (E NOE ) consisted of all 20 models of apo-TAR downloaded from the PDB (1ANR) 41 . The randomly selected ensembles (E 0,ran and E 1,ran ) were constructed using a random-number generator to randomly select 20 structures from the two pools of TAR conformations generated using MD simulations 23,24 containing 10,000 MD0 and 80,000 MD1 conformations. Another ensemble was generated by clustering MD0 into 20 clusters by heavy-atom r.m.s. deviation of all nonterminal nucleotides and taking representative structures from each cluster (E 0,clus ). Finally, an ensemble that poorly agreed with all four RDC datasets (E 0,anti ) was generated using a sample-and-select (SAS) Monte Carlo selection scheme to maximize the χ 2 function assessing the agreement between measured and predicted RDCs (equation (7)) 23 2 where i runs over all the RDCs measured for the different constructs j, and δ is the weight used to normalize different RDC datasets, which is set at one-tenth of the range of RDCs measured for each TAR construct 24 . D exp are the experimentally measured RDCs and D calc are the predicted RDCs that were calculate by PALES 70, 71 as described below. The quality of the various TAR ensembles used in this study was determined by evaluating how well they agree with four sets of RDC data measured on variably elongated TAR RNA molecules, as described previously 24 . Briefly, the PALES program 70, 71 was used to calculate predicted RDCs based on the structures in the ensemble, after in silico elongation as described previously 24 . A scaling factor was used to account for variations in experimental conditions. The predicted RDCs are averaged for all structures of the ensemble assuming equal probabilities (equation (8))
where k runs over the N conformers of the ensemble, λ j is the scaling factor for the jth TAR construct, and D i,j is the ith coupling in the jth construct. These calculated RDCs were then compared to measured RDCs, and the r.m.s. deviation (Hz) was calculated. [49] [50] [51] were used to assess the quality of NOE-based NMR structures of TAR in complex with arginine (1ARJ) 48 , acetylpromazine (1LVJ) 44 and neomycin B (1QD3) 47 . Specifically, we computed the r.m.s. deviation between the measured RDCs and values calculated when using the best-fit order tensor determined using RAMAH 72 .
Fitting RDCs to ligand-bound NMR structures. Previously published one-bond C-H RDCs
Benchmarking docking predicted poses. Using an updated set of ligand-bound RNA structures from the PDB that include 123 X-ray (90 with N flex ≤ 11) and 26 NMR (17 with N flex ≤ 11) structures ( Supplementary Table 3 ), we redocked each structure 20 times using the same docking procedure as described above. The binding pockets in the NMR structures were defined as any residue within 5 Å of the small molecule. Complexes with metal interactions near the binding site were not included in this benchmark. The r.m.s. deviation between the redocked structure and the original pose was calculated using the heavy atoms of the ligand for the best scoring pose over 20 runs.
Computing interhelical angles. EBVS was used to predict interhelical angles for six TAR-ligand complexes, and values were compared to interhelical angles in the NOE-based NMR structures of the complexes (acetylpromazine (1LVJ) 44 , rbt550 (1UTS) 45 , rbt203 (1UUD) 46 , rbt205 (1UUI) 46 , neomycin B (1QD3) 47 , and arginine (1ARJ) 48 ). For each of these molecules, docking against a TAR ensemble was repeated 20 times using the protocol described above. The interhelical angles (α h , β h , γ h ) were computed for each conformer of all ensembles, as well as for each model of the bound TAR NMR structures, using in-house software as described previously 49 . For this calculation, the lower helix was defined by base pairs C19-G43, A20-U42, and G21-C41, and the upper helix was defined by base pairs G26-C39, A27-U38, and G28-C37. For each docking run, the interhelical angles were population-weighted based on the Boltzmann-weighted docking scores and averaged over all 20 replicates. The interhelical angles for the NOE-based NMR bundles were averaged over all models assuming equal populations.
Analysis of ligand-bound poses.
Ligand poses predicted by EBVS were compared to the NOE-based NMR structures for six-ligand TAR complexes by computing the heavy-atom r.m.s. deviation between ligands after superimposing structures by both the ligand and RNA binding pocket (defined as any residue within 5 Å of the ligand in the NMR structure). As a control, we first redocked all ligands to the lowest energy NMR structure 20 times using the same docking protocol as above, defining the binding pocket as all resides within 5 Å of the ligand. The r.m.s. deviation values were calculated for the best scoring pose over all 20 runs. Next, each ligand was docked to E 0,4rdc or E 0,ran ensembles 20 times using the same docking protocol. For each run, the ligand r.m.s. deviation was calculated for the best scoring pose(s) from EBVS (some runs resulted in two significantly (> 25%) populated poses) to all structures in the NMR bundle, and the best-fit RMSDs over all 20 runs were averaged.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary.
Data availability.
Results from the high-throughput screen have been deposited on PubChem (AID: 1259389). The SDF files for the Full, Filtered, and Optimized libraries have been made available at https://sites.duke.edu/alhashimilab/ resources/. All other data can be made available upon reasonable request. 
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